Literature DB >> 1993206

Isolation and chemical characterization of two structurally and functionally distinct forms of botrocetin, the platelet coagglutinin isolated from the venom of Bothrops jararaca.

Y Fujimura1, K Titani, Y Usami, M Suzuki, R Oyama, T Matsui, H Fukui, M Sugimoto, Z M Ruggeri.   

Abstract

Two distinct forms of botrocetin, the von Willebrand factor (vWF)-dependent platelet coagglutinin isolated from the venom of the snake Bothrops jararaca, were purified and characterized structurally and functionally. The apparent molecular mass of the one-chain botrocetin was 28 kDa before and 32 kDa after reduction of disulfide bonds, while that of the two-chain botrocetin was 27 kDa before and 15/14.5 kDa after reduction. Amino acid composition of the two species revealed a similar high content of potentially acidic residues (greater than 60 Asx and Glx residues/molecule) but significant differences in the content of Cys and Phe residues. The NH2-terminal sequence of the one-chain botrocetin was Ile-Ile/Val-Ser-Pro-Pro-Val-Cys-Gly-Asn-Glu-. Two constituent polypeptides of the two-chain botrocetin showed similar but different NH2-terminal sequences, distinct from that of the one-chain species: (alpha) Asp-Cys-Pro-Ser-Gly-Trp-Ser-Ser-Tyr-Glu- and (beta) Asp-Cys-Pro-Pro-Asp-Trp-Ser-Ser-Tyr-Glu-. The carbohydrate content of both species was less than 2% of the total mass, and the pI was 4.0-4.1 for the one-chain species, and 4.6, 5.3-5.4, and 7.7-7.8 for the two-chain species. No free sulfhydryl group was detected in each species. Both types of botrocetin were resistant to proteolysis at neutral pH. Incubation of 125I-labeled one-chain botrocetin with the crude venom solution resulted in no detectable structural change. On a weight basis, the two-chain botrocetin was 34 times more active than the one-chain form in promoting vWF binding to platelets.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1993206     DOI: 10.1021/bi00221a032

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Primary structure of two-chain botrocetin, a von Willebrand factor modulator purified from the venom of Bothrops jararaca.

Authors:  Y Usami; Y Fujimura; M Suzuki; Y Ozeki; K Nishio; H Fukui; K Titani
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

2.  AlphaB-crystallin, a low-molecular-weight heat shock protein, acts as a regulator of platelet function.

Authors:  O Kozawa; H Matsuno; M Niwa; D Hatakeyama; K Kato; T Uematsu
Journal:  Cell Stress Chaperones       Date:  2001-01       Impact factor: 3.667

3.  The interaction between components of the fibrinolytic system and GPIb/V/IX of platelets thrombus formation in mice.

Authors:  H Matsuno; O Kozawa; S Ueshima; O Matsuo; D Collen; T Uematsu
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

4.  Tokaracetin, a new platelet antagonist that binds to platelet glycoprotein ib and inhibits von Willebrand factor-dependent shear-induced platelet aggregation.

Authors:  T Kawasaki; Y Taniuchi; N Hisamichi; Y Fujimura; M Suzuki; K Titani; Y Sakai; S Kaku; N Satoh; T Takenaka
Journal:  Biochem J       Date:  1995-06-15       Impact factor: 3.857

5.  Point mutation in a leucine-rich repeat of platelet glycoprotein Ib alpha resulting in the Bernard-Soulier syndrome.

Authors:  J Ware; S R Russell; P Marchese; M Murata; M Mazzucato; L De Marco; Z M Ruggeri
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

6.  O-linked carbohydrate of recombinant von Willebrand factor influences ristocetin-induced binding to platelet glycoprotein 1b.

Authors:  J A Carew; S M Quinn; J H Stoddart; D C Lynch
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

7.  Promotion of binding of von Willebrand factor to platelet glycoprotein Ib by dimers of ristocetin.

Authors:  M F Hoylaerts; K Nuyts; K Peerlinck; H Deckmyn; J Vermylen
Journal:  Biochem J       Date:  1995-03-01       Impact factor: 3.857

8.  Tracking the recruitment and evolution of snake toxins using the evolutionary context provided by the Bothrops jararaca genome.

Authors:  Diego Dantas Almeida; Vincent Louis Viala; Pedro Gabriel Nachtigall; Michael Broe; H Lisle Gibbs; Solange Maria de Toledo Serrano; Ana Maria Moura-da-Silva; Paulo Lee Ho; Milton Yutaka Nishiyama-Jr; Inácio L M Junqueira-de-Azevedo
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-18       Impact factor: 11.205

Review 9.  Inflammation Induced by Platelet-Activating Viperid Snake Venoms: Perspectives on Thromboinflammation.

Authors:  Catarina Teixeira; Cristina Maria Fernandes; Elbio Leiguez; Ana Marisa Chudzinski-Tavassi
Journal:  Front Immunol       Date:  2019-09-04       Impact factor: 7.561

Review 10.  Snake Venoms in Drug Discovery: Valuable Therapeutic Tools for Life Saving.

Authors:  Tarek Mohamed Abd El-Aziz; Antonio Garcia Soares; James D Stockand
Journal:  Toxins (Basel)       Date:  2019-09-25       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.